Directory
>
Aaron Goldman
Aaron Goldman
Translational Technologies | Xsphera Biosciences Inc
Boston, Massachusetts, United States
Aaron Goldman
AI Summary
Aaron Goldman is a dedicated professional in the Healthcare, Pharmaceuticals, and Biotech sector, currently serving on the Scientific Advisory Board at Celularity. With a strong focus on scientific innovation, he is passionate about advancing healthcare solutions that improve patient outcomes. Although his educational background and prior industry experience are not detailed, his role suggests a high level of expertise and influence in his field. Aaron is likely to be involved in strategic decision-making processes, contributing to the development of cutting-edge therapies. His commitment to the industry indicates a long-term vision for healthcare advancements. He operates within a dynamic and evolving sector, which requires adaptability and a forward-thinking mindset. Aaron's contributions are essential in navigating the complexities of modern healthcare challenges. His profile reflects a blend of scientific acumen and strategic advisory capabilities.
Aaron Goldman
Work Experience
Translational Technologies at
Danaher Corporation
December 2023 - Present
Operating Partner at
BroadOak Capital Partners
September 2023 - Present
Advisory Board Member at
Tessellate Therapeutics
March 2023 - Present
Scientific Advisory Board Member at
Celularity Inc.
September 2021 - Present
Translational Research Process Advisor at
Xsphera Biosciences Inc
January 2020 - Present
Faculty, Instructor in Medicine and Director at
Harvard University
July 2015 - Present
Sr. Director, Translational Research Business Development, Alliance Management at
Ovid Therapeutics
October 2022 - August 2023
Sr. Director, Translational Research at
Ovid Therapeutics
February 2022 - October 2022
Co-Founder, President and CEO at
Transporter Therapeutics Inc.
January 2021 - February 2022
Entrepreneur In Residence at
Xontogeny
December 2019 - January 2022
Director, R&D and Global Head of Immuno-Oncology at
Farcast Biosciences
May 2018 - December 2019
Legislative Ambassador at
American Cancer Society Cancer Action Network (ACS CAN)
July 2015 - July 2019
Associate Director, R&D and Immuno Oncology at
Farcast Biosciences
October 2016 - May 2018
Post Doctoral fellow at
Harvard University
February 2011 - July 2015
Congressional Intern at
U.S. House of Representatives
August 2010 - December 2010
Graduate Student at
The University Of Arizona
August 2006 - December 2010
Literature Research Scientist at
Miraca Life Sciences
December 2007 - April 2009
Aaron Goldman
Education
Harvard Medical School, Post-Doctoral Training
January 2011 - January 2015
University of Arizona College of Medicine – Tucson, Doctor Of Philosophy (Ph.D.)
January 2006 - January 2010
University of Arizona Honors College, Bachelor Of Science (B.S.) Philosophy (Minor)
January 2001 - January 2006
Frequently Asked Questions about Aaron Goldman
What is Aaron Goldman email address?
Aaron Goldman's primary email address is *************@celularity.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Aaron Goldman work for?
Aaron Goldman is a Translational Technologies at Xsphera Biosciences Inc, a company specializing in Commercial physical research.
Where Aaron Goldman graduated from?
Aaron Goldman holds a degree in Translational Medicine And Bioengineering from Harvard Medical School.
How can I directly contact Aaron Goldman?
To contact Aaron Goldman directly, you can use the email address *************@celularity.com. Complete contact information is available upon registration with Muraena.
Who is Aaron Goldman?
Aaron Goldman is a dedicated professional in the Healthcare, Pharmaceuticals, and Biotech sector, currently serving on the Scientific Advisory Board at Celularity. With a strong focus on scientific innovation, he is passionate about advancing healthcare solutions that improve patient outcomes. Although his educational background and prior industry experience are not detailed, his role suggests a high level of expertise and influence in his field. Aaron is likely to be involved in strategic decision-making processes, contributing to the development of cutting-edge therapies. His commitment to the industry indicates a long-term vision for healthcare advancements. He operates within a dynamic and evolving sector, which requires adaptability and a forward-thinking mindset. Aaron's contributions are essential in navigating the complexities of modern healthcare challenges. His profile reflects a blend of scientific acumen and strategic advisory capabilities.
Aaron`s contact details
*************@celularity.com
*************@harvard.edu
********@email.arizona.edu
*********@partners.org
********@broadoak.com